Please assess the completion status of the following clinical trial:

Trial Title: A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A primary psychiatric diagnosis of Major Depressive Disorder as defined by DSM-IV~* Diagnosis of prostate, colorectal, lung or pancreatic cancer (stage 1-4)~* A score of 16 or above in the 17-item HAM-D (Hamilton depression scale)~* Male or female ages 18-75.~* Ability to give consent~* English and/ or Spanish Speaking~Exclusion Criteria:~* Lifetime history of psychosis or bipolar disorder~* History of substance abuse or dependence in the three months prior to the study.~* Current suicide risk.~* Patients who have ever failed IPT in the context of cancer.~* Patients who are receiving effective medication for depression~* Patients with T3, T4 and THS abnormal values

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Interpersonal Psychotherapy (IPT) (Type: EXPERIMENTAL): Interpersonal psychotherapy (IPT) is a brief, manualized therapy that has shown efficacy in the treatment of major depressive disorder (MDD) in several controlled trials. This study will test the efficacy of IPT in a group of prostate, colorectal, lung and pancreatic cancer patients with a diagnosis of major depressive disorder.

Based on this trial design, predict the completion outcome and termination type (if applicable).